[Public Comment Submission] “National Action Plan for Pandemic Influenza and New Infectious Diseases (Draft)” (May 7, 2024)
date : 6/3/2024
Tags: AMR, Vaccinations
Health and Global Policy Institute’s Antimicrobial Resistance (AMR) Team and Vaccinations Team submitted their written opinion on the draft of “National Action Plan for Pandemic Influenza and New Infectious Diseases” by the Cabinet Agency for Infectious Disease Crisis Management (CAICM), the Cabinet Secretariat.
As the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases notes in its preamble, mankind has overcome a variety of infectious diseases. However, the threat of new and re-emerging infectious diseases persists, and Coronavirus Disease 2019 (COVID-19) will not be the last infectious disease crisis. Instead of continuing to respond with panic and neglect when faced with the ever-changing circumstances of a health crisis, we must implement all possible prevention and preparedness when emergencies are not occurring to minimize the impact of future health crises as well as to reinforce our capacity for response to such events. Particularly pressing issues include researching and developing vaccines, diagnostics, and therapeutics, and ensuring their smooth and stable supply; and developing human resources related to infectious disease countermeasures.
CAICM was established in September 2023 to reinforce the Government’s capacity to serve as a central command tower during both ordinary times as well during emergencies. Making the most of lessons from the COVID-19 pandemic, the National Action Plan for Pandemic Influenza and New Infectious Diseases is now set to be revised according to the Act on Special Measures for Pandemic Influenza and New Infectious Diseases Preparedness and Response to strengthen prevention, preparedness, and response (PPR) for the next infectious disease crisis. It will include measures for addressing unjust discrimination or bias against patients with infectious diseases as well as for handling false or misleading information.
Key points of our public comment
- In addition to patients with infectious diseases, their families, and healthcare professionals, steps should also be taken to prevent discrimination or prejudice against businesses that may be suspected of being hotbeds for the spread of infections.
- To contribute to the smooth rollout of vaccines, etc. during emergencies and to minimize the incidence of serious illness and death, it will be important to review the structure of the system for routine vaccinations during periods of non-emergency (i.e., preparatory periods) to ensure it is ideal.
- When promoting research and development (R&D) for vaccines, diagnostics, and therapeutics, centered on Medical Countermeasures (MCMs) that will be vital in responding to infectious disease crises, it will be necessary to provide pull incentives that support R&D over multiple years.
- Training infectious disease specialists, technical staff, and other human resources will be vital. When doing so, it will be essential to engage in collaboration that surpasses the Cabinet Secretariat—which is responsible for formulating the National Action Plan—to include the Ministry of Health, Labour and Welfare, the Ministry of Finance, and the Ministry of Education, Culture, Sports, Science and Technology.
For more information on this public comment, please click here (only available in Japanese).
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)